Baillie Gifford - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$730,000
+9.4%
219,4000.0%0.00%0.0%
Q3 2019$667,000
+27.5%
219,4000.0%0.00%0.0%
Q2 2019$523,000
-36.5%
219,4000.0%0.00%0.0%
Q1 2019$823,000
+4.6%
219,4000.0%0.00%0.0%
Q4 2018$787,000
-37.4%
219,4000.0%0.00%0.0%
Q3 2018$1,257,000
+14.4%
219,4000.0%0.00%0.0%
Q2 2018$1,099,000
-2.3%
219,4000.0%0.00%0.0%
Q1 2018$1,125,000
-14.6%
219,4000.0%0.00%
-50.0%
Q4 2017$1,318,000
+8.2%
219,4000.0%0.00%0.0%
Q3 2017$1,218,000
+19.6%
219,4000.0%0.00%
+100.0%
Q2 2017$1,018,000
-6.3%
219,4000.0%0.00%
-50.0%
Q1 2017$1,086,000
-55.4%
219,4000.0%0.00%
-50.0%
Q4 2016$2,435,000
+19.8%
219,4000.0%0.00%
+33.3%
Q3 2016$2,032,000
+45.9%
219,4000.0%0.00%
+50.0%
Q2 2016$1,393,000
-2.6%
219,4000.0%0.00%
-33.3%
Q1 2016$1,430,000
-19.7%
219,4000.0%0.00%0.0%
Q4 2015$1,780,000
+10.7%
219,4000.0%0.00%0.0%
Q3 2015$1,608,000
-17.2%
219,400
+15.8%
0.00%0.0%
Q2 2015$1,942,000189,4000.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$28,738,0004.90%
DSC Advisors, L.P. 1,187,604$7,138,0004.14%
Opaleye Management Inc. 960,000$5,769,0001.85%
DAFNA Capital Management LLC 352,741$2,120,0001.14%
Vivo Capital, LLC 855,000$5,139,0001.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 382,838$2,301,0000.81%
SENZAR ASSET MANAGEMENT, LLC 377,397$2,268,0000.58%
Sio Capital Management, LLC 131,200$789,0000.44%
Perceptive Advisors 1,117,324$6,715,0000.22%
Tekla Capital Management LLC 930,398$5,592,0000.22%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders